Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 70Neoplasm Metastasis 11Prostatic Neoplasms 9Pain 8Osteoporosis 8Multiple Myeloma 5Humoral Hypercalcemia Of Malignancy 4Triple Negative Breast Neoplasms 3Bone Diseases, Metabolic 3Neoplasms 2Lung Neoplasms 2Breast Neoplasms, Male 2Bone Neoplasms 2Bone Diseases 2Renal Insufficiency 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Neoplasm Micrometastasis 1Metastatic Breast Cancer With Bone Involvement 1Hereditary Breast and Ovarian Cancer Syndrome 1Fractures, Bone 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Metastatic 1

Interventions

veliparib 1pembrolizumab 1Zoledronic Acid 1Taxes 1Paclitaxel 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Zoledronic Acid × Breast × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡